Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination
Authors
Keywords
-
Journal
npj Vaccines
Volume 2, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-12-13
DOI
10.1038/s41541-017-0038-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex
- (2017) Sha Ha et al. JOURNAL OF VIROLOGY
- Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial
- (2016) David I. Bernstein et al. VACCINE
- Preclinical evaluations of peptide-conjugate vaccines targeting the antigenic domain-2 of glycoprotein B of human cytomegalovirus
- (2016) Adam C. Finnefrock et al. Human Vaccines & Immunotherapeutics
- Reconstitution of Human Cytomegalovirus–Specific CD4 + T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection
- (2015) Elisa Gabanti et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A cytomegalovirus DNA vaccine induces antibodies that block viral entry into fibroblasts and epithelial cells
- (2015) Michael A. McVoy et al. VACCINE
- Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody
- (2015) Sumana Chandramouli et al. Nature Communications
- Crystal Structure of the Human Cytomegalovirus Glycoprotein B
- (2015) Heidi G. Burke et al. PLoS Pathogens
- A High-Affinity Native Human Antibody Neutralizes Human Cytomegalovirus Infection of Diverse Cell Types
- (2014) Lawrence M. Kauvar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease
- (2014) Tong-Ming Fu et al. VACCINE
- Development of a High-Throughput Assay To Measure the Neutralization Capability of Anti-Cytomegalovirus Antibodies
- (2013) Thomas J. Gardner et al. Clinical and Vaccine Immunology
- Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine
- (2013) D. C. Freed et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus
- (2012) Tong-Ming Fu et al. VACCINE
- Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
- (2011) Paul D Griffiths et al. LANCET
- A novel high-throughput neutralization assay for supporting clinical evaluations of human cytomegalovirus vaccines
- (2011) Aimin Tang et al. VACCINE
- B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies
- (2011) Sonja Pötzsch et al. PLoS Pathogens
- Update on the current status of cytomegalovirus vaccines
- (2010) Heungsup Sung et al. Expert Review of Vaccines
- Isolation of Human Monoclonal Antibodies That Potently Neutralize Human Cytomegalovirus Infection by Targeting Different Epitopes on the gH/gL/UL128-131A Complex
- (2009) A. Macagno et al. JOURNAL OF VIROLOGY
- Recombinant human monoclonal antibodies to human cytomegalovirus glycoprotein B neutralize virus in a complement-dependent manner
- (2009) Akane Ohta et al. MICROBES AND INFECTION
- Vaccine Prevention of Maternal Cytomegalovirus Infection
- (2009) Robert F. Pass et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection
- (2008) Xiaohong Cui et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started